The past decade has shown tremendous advances in the care of patients with lung cancer. With improved survival comes the opportunity for patients to become survivors who advocate for research by attending conferences, forming relationships with physicians and care providers, and lending their voices through committee involvement and speaking opportunities. The IASLC offers several opportunities to help transform patients into patient research advocates.
Patient Advocacy Spotlights

IASLC Urges Congress to Fund the Lung Cancer Research Program
The International Association for the Study of Lung Cancer is one of 55 groups that have signed on to urge Congress to allocate $60 million to the Lung Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP) in the Fiscal Year 2023 Department of Defense appropriations bill.